CA
BIIB icon

CoreCap Advisors’s Biogen BIIB Stock Holding History

CoreCap Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Buy
858
+604
+238% +$116K 0.01% 886
2026
Q1 		$46.6K Sell
254
-3,022
-92% -$557K ﹤0.01% 1338
2025
Q4 		$577K Buy
3,276
+3,077
+1,546% +$503K 0.02% 483
2025
Q3 		$27.9K Sell
199
-150
-43% -$20.3K ﹤0.01% 1552
2025
Q2 		$43.8K Sell
349
-3
-0.9% -$374 ﹤0.01% 1306
2025
Q1 		$48.2K Sell
352
-56
-14% -$8.01K ﹤0.01% 1182
2024
Q4 		$62.4K Buy
408
+63
+18% +$10.6K ﹤0.01% 1091
2024
Q3 		$66.9K Sell
345
-125
-27% -$26.2K ﹤0.01% 1073
2024
Q2 		$109K Buy
470
+125
+36% +$27.2K 0.01% 479
2024
Q1 		$74.4K Buy
+345
New +$80.8K ﹤0.01% 965
2022
Q4 		$2.06M Buy
+7,445
New +$2.1M 0.15% 121
2022
Q3 		– Sell
-510
Closed -$104K – 695
2022
Q2 		$104K Buy
+510
New +$104K 0.01% 674
2022
Q1 		– Sell
-489
Closed -$117K – 706
2021
Q4 		$117K Buy
+489
New +$126K 0.01% 694

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CoreCap Advisors's BIIB Position: Q2 2026 in Review

CoreCap Advisors increased its Biogen (BIIB) stake by 238% in Q2 2026, buying an estimated $116K and bringing the position to 858 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #886.

CoreCap Advisors first reported a position in BIIB in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.06M in Q4 2022. 221 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • CoreCap Advisors held 858 shares of Biogen worth $185K as of Q2 2026.
  • CoreCap Advisors bought 604 Biogen shares in Q2 2026, an estimated $116K.
  • Biogen made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #886 holding.
  • CoreCap Advisors first reported a position in Biogen in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Biogen position peaked at $2.06M in Q4 2022.
  • 221 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.